logo-loader

EXMceuticals secures critical R&D license for its Portugal cannabis facilities

Published: 09:36 30 Oct 2019 EDT

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Andrew Scott following the news they've obtained a licence for cannabis research and development from the Portuguese government.

The license was granted by INFARMED - the Portuguese National Authority of Medicines and Health Products. 

Summers says it allows them to now take a huge step forward in its European operations by being able to import, research and refine cannabinoids and cannabis by-products.

EXMceuticals now '100% focused on being a refining bioscience business in...

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development. Summers explains that the company has recently transitioned from being active in Africa to focusing their attentions solely onto Portugal. The company...

on 14/9/20